Description
Mounjaro is a once-weekly injectable medication specifically designed for managing blood sugar levels in adults with type 2 diabetes. It contains tirzepatide, a GLP-1 receptor agonist that helps lower blood sugar by improving insulin secretion and reducing glucose production.
In addition to its primary use for type 2 diabetes, Mounjaro has been associated with weight loss in some patients, though it is not — for weight loss.
Always consult your healthcare provider before starting Mounjaro to determine if it’s right for you.
| Product Name | Mounjaro |
|---|---|
| Active Ingredient | Tirzepatide |
| FDA Approval Status | Approved for Type 2 Diabetes |
| Common Dosage | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg (weekly injections) |
| Uses | Blood sugar management for Type 2 Diabetes, weight loss (off-label use) |
| Storage | Refrigeration required (2-8°C) |
